Navigation Links
DTRA/SCC-WMD Announces $1 Million Algorithm Challenge
Date:12/13/2012

Fort Belvoir, VA (PRWEB) December 13, 2012

Nuclear warheads are not the only weapons of mass destruction threatening the United States and her allies. Because nuclear weapons require sophisticated technologies and elements difficult to obtain, the nation’s adversaries may find chemical and biological weapons easier to procure.

The Defense Threat Reduction Agency/U.S. STRATCOM Center for Combating Weapons of Mass Destruction (DTRA/SCC-WMD) is working hard to protect American warfighters and our allies from threats posed by chemical and biological weapons by innovating new technologies to detect chem/bio threats.

DTRA/SCC-WMD’s most recent initiative is “The DTRA Algorithm Challenge” – an open competition with a $1 million prize for the individual or team that develops an algorithm which can most rapidly and accurately characterize a complex clinical sample based solely on raw DNA sequence data.

“The Algorithm Challenge will lead to an enhancement of DTRA’s capability to diagnose and treat biothreats to the U.S. Armed Forces by giving DoD the ability to process and analyze biological sequence data rapidly in a realistic, moderate-to-low resource setting,” said Dr. Christian Whitchurch, Devices Branch Manager for DTRA’s Diagnostics, Detection and Disease Surveillance Division. “DTRA believes an open innovation development strategy is most likely to quickly yield a set of disruptive solutions to the threats posed by known, emerging, or engineered pathogens.”

This particular algorithm challenge focuses on using DNA sequence data in identifying pathogens in complex mixtures from clinical samples. By using sequencing as a diagnostic tool for infectious disease, the DoD will eventually have the ability to diagnose a larger number of threats (known and unknown) than ever before.

The Challenge winner will be whichever individual- or team-developed algorithm that best meets the following criteria:

  • Assesses the data, however complete or limited
  • Provides the best possible characterization of the sample
  • Identifies and quantifies all components when possible
  • Speculates (with probability and justification) when positive ID is not possible
  • Makes recommendations for further analysis
  • Does not rely on an expert user
  • Requires little overhead
  • Is fast

“Diagnostics is a critical area of emphasis for DTRA in creating new capabilities and products in detecting chemical and biological threats whether natural or intentional,” said Dr. Alan Rudolph, DTRA’s Director of Chemical/Biological Technologies. “The Algorithm prize is a great example where we are looking for novel solutions from advanced mathematics to unlock complex human diagnostic data to better determine health status that could inform on early and effective treatment options to these threats.”

Prize details and sequencing datasets will be made available in January 2013. For more information about the DTRA Challenge, visit the challenge website at http://www.innocentive.com/dtra.

DTRA is a combat support agency of the U.S. Department of Defense, founded in 1998, headquartered at Fort Belvoir, Virginia. Its mission is to safeguard the United States and her Allies from Weapons of Mass Destruction (Chemical, Biological, Radiological, and Nuclear) and High-Yield Explosives by providing capabilities to reduce, eliminate and counter the threat, and mitigate its consequences. Visit us on the Web at http://www.dtra.mil.

No. DTRA 2012-004

Read the full story at http://www.prweb.com/releases/dtra/algorithm/prweb10233480.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galileo Analytics Announces Agreement to Provide Analytic Component of ASCOs CancerLinQ Prototype
2. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida
3. Accelr8 Announces NASDAQ Capital Market Listing
4. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
5. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
6. Career Confidential Announces Release of New E-book About Using Recruiters
7. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
8. Innosight Announces Leadership Transition
9. My Cleaning Products Announces its Christmas Special, Sells Rusterizer at 20% Less
10. GenScript Announces Collaboration with AMDeC: Seeks to Decrease Biological Research Costs at NYC Area Institutions
11. Sequenom Announces Leadership Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... In starting a program to hire college athletes, Catalyst COO ... skill.” , In keeping with this philosophy, the Catalyst an Iowa premix manufacturer recently ... to replicate the practice throughout the company. , “I’ve heard coaches talk on television ...
(Date:2/24/2017)... FRANCISCO, CA (PRWEB) , ... February 24, 2017 , ... ... of a $224K grant from the National Institute of Mental Health (NIMH) for the ... based on Delpor’s PROZOR technology and is expected to deliver therapeutic levels ...
(Date:2/24/2017)... N.J. , Feb. 24, 2017  Driven ... and biotechnology are now the fastest growing categories, ... Specialty Actives in Personal Care: Multi-regional Market ... research and management consulting firm Kline. ... bioprocesses that make them more effective for skin ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
Breaking Biology Technology:
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
Breaking Biology News(10 mins):